Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex W Tong

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Seminars in Oncology|April 30, 2003
Human monoclonal macroglobulins with antibody activityMarvin J Stone, Yolonda G McElroy, Alan Pestronk, et al.
Clinical Lymphoma|March 30, 2005
Immunoglobulin M myeloma: evaluation of molecular features and cytokine expressionKartik Konduri, Surinder S Sahota, Gavin Babbage, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2009
Growth inhibition of human multiple myeloma cells by an oncolytic adenovirus carrying the CD40 ligand transgeneMargret S Fernandes, Erica M Gomes, Lindsay D Butcher, et al.
Cancer Gene Therapy|April 30, 2003
Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patientsJohn Nemunaitis, Casey Cunningham, Alex W Tong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Antitumor activity of an oncolytic adenoviral-CD40 ligand (CD154) transgene construct in human breast cancer cellsErica M Gomes, Margret S Rodrigues, Anagha P Phadke, et al.
Gene Regulation and Systems Biology|October 20, 2009
Safety and in vivo expression of a GNE-transgene: a novel treatment approach for hereditary inclusion body myopathy-2Anagha P Phadke, Chris Jay, Salina J Chen, et al.
The Journal of Gene Medicine|May 5, 2010
Hereditary inclusion body myopathy: single patient response to GNE gene Lipoplex therapyGregory Nemunaitis, Phillip B Maples, Chris Jay, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 26, 2009
A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumorsJohn Nemunaitis, Alex W Tong, Michael Nemunaitis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 9, 2004
Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patientsAlex W Tong, John Nemunaitis, Dan Su, et al.
Human Gene Therapy|April 27, 2011
Hereditary inclusion body myopathy: single patient response to intravenous dosing of GNE gene lipoplexGregory Nemunaitis, Chris M Jay, Phillip B Maples, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Seminars in Oncology|April 30, 2003
Human monoclonal macroglobulins with antibody activityMarvin J Stone, Yolonda G McElroy, Alan Pestronk, et al.
Clinical Lymphoma|March 30, 2005
Immunoglobulin M myeloma: evaluation of molecular features and cytokine expressionKartik Konduri, Surinder S Sahota, Gavin Babbage, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2009
Growth inhibition of human multiple myeloma cells by an oncolytic adenovirus carrying the CD40 ligand transgeneMargret S Fernandes, Erica M Gomes, Lindsay D Butcher, et al.
Cancer Gene Therapy|April 30, 2003
Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patientsJohn Nemunaitis, Casey Cunningham, Alex W Tong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Antitumor activity of an oncolytic adenoviral-CD40 ligand (CD154) transgene construct in human breast cancer cellsErica M Gomes, Margret S Rodrigues, Anagha P Phadke, et al.
Gene Regulation and Systems Biology|October 20, 2009
Safety and in vivo expression of a GNE-transgene: a novel treatment approach for hereditary inclusion body myopathy-2Anagha P Phadke, Chris Jay, Salina J Chen, et al.
The Journal of Gene Medicine|May 5, 2010
Hereditary inclusion body myopathy: single patient response to GNE gene Lipoplex therapyGregory Nemunaitis, Phillip B Maples, Chris Jay, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 26, 2009
A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumorsJohn Nemunaitis, Alex W Tong, Michael Nemunaitis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 9, 2004
Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patientsAlex W Tong, John Nemunaitis, Dan Su, et al.
Human Gene Therapy|April 27, 2011
Hereditary inclusion body myopathy: single patient response to intravenous dosing of GNE gene lipoplexGregory Nemunaitis, Chris M Jay, Phillip B Maples, et al.
Pageof 3